Villefrance de Lauragais, France

Jean-Louis Avan

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Villefranche de Lauragus, FR (2004)
  • Villefranche de Lauragai, FR (2009)
  • Villefranche de Lauragais, FR (2013)
  • Villefrance de Lauragais, FR (2008 - 2015)

Company Filing History:


Years Active: 2004-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jean-Louis Avan

Introduction

Jean-Louis Avan is a notable inventor based in Villefranche de Lauragais, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable pharmaceutical compositions. With a total of 6 patents to his name, Avan's work has the potential to impact cancer treatment and other medical applications.

Latest Patents

Among his latest patents, Avan has developed a stable pharmaceutical composition comprising a hydrosoluble vinflunine salt. This composition is designed for oral administration and is preferably in the form of a capsule or tablet. The hydrosoluble vinflunine salt is identified as Vinflunine ditartrate. Additionally, he has patented a pharmaceutical composition based on idazoxan, which includes its salts, hydrates, or polymorphs. These innovations aim to enhance the efficacy and delivery of therapeutic agents in cancer treatment.

Career Highlights

Jean-Louis Avan is associated with Pierre Fabre Medicament, a company known for its commitment to pharmaceutical innovation. His work at this organization has allowed him to focus on developing advanced pharmaceutical formulations that address critical health challenges.

Collaborations

Avan has collaborated with notable colleagues such as Joël Bougaret and Roland Segonds. These partnerships have likely contributed to the success and development of his innovative pharmaceutical compositions.

Conclusion

Jean-Louis Avan's contributions to pharmaceutical innovation are noteworthy, particularly in the realm of cancer treatment. His patents reflect a commitment to improving patient outcomes through advanced drug formulations. His work continues to inspire advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…